Precision Health and PGx Podcast

Improving Market Access and Reimbursement for PGX Diagnostics | PGX for Pharmacists

ALVA10: the Power of Diagnostics 
Have you ever questioned why a payer pays for a medication, yet does not pay for the diagnostic test to determine if the medication will be efficacious and non-toxic for the patient?
Or perhaps, you may have wondered why payers agree to pay for a medication for which no diagnostic test exists to diagnose the condition the medication treats? 
If these types of questions keep you awake at night like they do me, please join me for this podcast episode in which I and my esteemed colleagues, Hannah Mamuszka and Lena Chaihorsky of Alva10 discuss answers to these questions and the general state of the pharmacogenomics market access and reimbursement landscape. 
Lena Chaihorsky & Hannah Mamuszka join Dr. Becky Winslow to discuss diagnostic testing and the preventative savings for PGX testing for patients on multiple medications. 
Episode Based on LI article written by Hannah:
https://www.linkedin.com/pulse/bigger-problem-aduhelm-we-dont-know-who-has-disease-hannah-mamuszka/?trackingId=GIb%2BLnNCys35sG19%2Fo0NFw%3D%3D
ALVA10: 
https://alva10dx.com/ 
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Pharmacogenomics Leader Series: Howard McLeod | PGX for Pharmacists

Today's episode of the PGX for Pharmacists podcast is hosted by Dr. Becky Winslow, PharmD. Dr. Winslow is a pharmacogenomics authority with more than twenty years of clinical pharmacotherapy and pharmacy business operations experience, which includes seven years of direct patient facing care, seven years of pharmacy management experience and six years of experience as a medical science liaison in the pharmacogenomics field. 
Dr Howard McLeod is an internationally recognized expert in precision medicine, having made novel contributions at the discovery, translation, implementation, and policy levels.  He is the Medical Director for Precision Medicine at the Geriatric Oncology Consortium and a Professor at the University of South Florida Taneja College of Pharmacy.  Howard received a BSPharm from University of Washington and a PharmD from the Philadelphia College of Pharmacy & Science. 
Dr. McLeod completed clinical pharmacology fellowship training at St Jude Children’s Research Hospital and then the Beatson Institute, University of Glasgow.  Dr McLeod has been a tenured full Professor since 2002 and involved in over $80,000,000 in peer reviewed funding. 
Dr McLeod chaired the NHGRI eMERGE network external scientific panel for the past decade and was a recent member of both the FDA committee on Clinical Pharmacology and the NIH Human Genome Advisory Council.  Dr McLeod has been recognized as a Fellow of both the American Society of Clinical Oncology and the American College of Clinical Pharmacy and was recently ranked #1 USA/#2 World for Pharmacogenomics.  He has also been an active Board Member and/or Founder for over a dozen privately held and publicly traded companies. 
Howard has published over 580 peer reviewed papers on pharmacogenomics, applied therapeutics, or clinical pharmacology and continues to work to advance innovative healthcare.
This episode of the PGX for Pharmacist podcast is sponsored by Pharmazam: 
https://pharmazam.com/PPN 
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Geriatric Pharmacist - DeLon Canterbury, PharmD | PGx for Pharmacists

DeLon Canterbury is a Board Certified Geriatric Pharmacist.  He founded GeriatRx, a telehealth-based senior care consulting company.  GeriatRx combines Pharmacogenomic testing and Comprehensive Medication Management. He addresses the social determinants of health. He helps reduce medication errors and advocates for de-prescribing. Dr. DeLon helps improve patient safety and saves patients, their families, and the healthcare system money.  He manages patients across the state of North Carolina and demonstrates the value pharmacists add to healthcare delivery.   Dr. DeLon is an active Executive Board Member for the African-American Minority COVID Task Force in Durham, North Carolina, a Formulary Committee member of Senior PharmAssist at the Durham Senior Center for Life. He served as Community Health Coalition’s Telehealth Director, helping older African-American patients with wellness and reassurance check-ups during COVID.  

The State of PGx Education (Part 2) | PGX for Pharmacists

PART TWO: Pharmacogenomics Education is critical to advancing the Pharmacist's optimal impact on medication management as a tool to ensure the drugs prescribed work as intended. 
The State of the Industry -- Pharmacogenomics Education
Clinical pharmacogenomics activities may include designing patient-specific drug and dosage regimens based on genetic profile, documenting clinical recommendations, educating pharmacists and other health care professionals, and recommending testing
Advanced training in pharmacogenomics may open up more practice opportunities for pharmacists, such as developing clinical decision support tools in electronic health record systems that guide prescribers on appropriate drug therapy regimens based on genetic profiles. Additionally, pharmacists can develop institutional guidelines and processes for implementing clinical pharmacogenomics services into various practice settings.
Pharmacists can also develop patient education materials to explain the significance of the tests and serve as expert consultants in a pharmacogenomics service.
Special guest: David Hurley PhD. 
David Hurley grew up in Dunwoody, GA, then earned a BS in Biology and Physics from Guilford College in Greensboro, NC, in 1979. He received his PhD in Molecular and Cellular Biology from Penn State University in 1986. He joined the faculty in Cell and Molecular Biology at Tulane University in New Orleans in 1992. He developed "Cellular Biochemistry" as a senior-level course for premedical students, while maintaining a research focus on the regulation of gene transcription of the Growth Hormone gene in the pituitary. Dr Hurley was an National Science Foundation CAREER program awardee from 1996-2004, and was co-investigator on a National Institutes of Health grant for 17 years. After the devastation of Hurricane Katrina, he joined the Gatton School of Pharmacy at East Tennessee State University as an inaugural faculty member in July, 2007, as Professor and Vice-Chair in the Department of Pharmaceutical Sciences. He has 45 publications, is a member of The Endocrine Society, the Society for Neuroscience, the AACP, and has been a grant reviewer for 6 years with the National Institute for Diabetes, Digestive and Kidney Diseases.
Our host: Becky Winslow, PharmD 
Dr. Becky Winslow is a co-host on PGX for Pharmacists. She’s an accomplished Doctor of Clinical Pharmacy with more than twenty years of clinical pharmacotherapy and pharmacy business operations experience, which includes seven years of direct patient facing care, seven years of pharmacy management experience and six years of experience as a medical science liaison in the pharmacogenomics field. Becky Winslow excels at developing and managing collaborative relationships with healthcare professionals and key opinion leaders to stay abreast of emerging trends and to achieve project goals. Becky Winslow is an articulate communicator with extensive background in gathering and critically analyzing research and data; translating complex content into a level appropriate to the target audience; writing clinical and marketing content; presenting; teaching; and training.
This episode of the PGX for Pharmacist's podcast is brought to you by RxSafe. 
Thanks RxSafe for Sponsoring this episode: 
RxSafe.com 
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

The Pharmacogenomics Fellowship| PGX For Pharmacists

Dr. Jai Patel, PharmD, BCOP, CPP Chair of Department of Cancer Pharmacology & Pharmacogenomics Dr. Jai Patel is a pharmacist who help create a pharmacogenomics fellowship which was not available at his school. He finished the Oncology/Pharmacogenomics Postdoctoral Fellowship at the UNC Eshelman School of Pharmacy. Dr. Patel: “I approached my mentor and said, ‘this is what I want to practice. I have the ambition and drive.’ I had to convince him I was a good investment. Just because something doesn’t exist, doesn’t mean it isn’t possible. That’s what will set you apart from others when trying to build something new. Health care is always changing. Position yourself to be in the forefront of medicine. Dr. Patel serves as Chair of the Department of Cancer Pharmacology and Pharmacogenomics at Levine Cancer Institute. He is also the associate Professor in the Division of Hematology/Oncology. Dr. Patel’s research focuses on translational and clinical pharmacogenomics and pharmacokinetics of anticancer therapies.  Behnaz Sarrami, MS, PharmD Pharmacogenomics (PGx) coach and consultant | MSL at Atheadx Behnaz Sarrami is the co-host to the PGx for Pharmacist Podcast. She is an expert in the field of PGx and mentor to pharmacist who are establishing their own PGx consulting business. She believes in personalizing a patient’s medication based on each individual’s genetic makeup and is keen in helping overcome barriers for both pharmacist and providers who want to implement PGx in any clinical setting. Behnaz received her Master’s degree in Biochemistry from Georgetown University and her Doctorate in Pharmacy from Creighton University. Behnaz has been a contributor of Washington University’s Public Health blog. She also serves as a consultant for a grant-funded research project which aims to increase medication adherence in older adults who suffer from mental health. This episode is sponsored by the Ultiguard Safe Pack. UltiGuard Safe Pack is the only pen needle product that comes with an all-in-one sharps container. Learn more about why UltiGuard Safe Pack is the best choice for your patients and your pharmacy.

Pharmacogenomics Education (Part 1) | PGX For Pharmacist

Pharmacogenomics Education is critical to advancing the Pharmacist's optimal impact on medication management as a tool to ensure the drugs prescribed work as intended. 
The State of the Industry -- Pharmacogenomics Education
Clinical pharmacogenomics activities may include designing patient-specific drug and dosage regimens based on genetic profile, documenting clinical recommendations, educating pharmacists and other health care professionals, and recommending testing
Advanced training in pharmacogenomics may open up more practice opportunities for pharmacists, such as developing clinical decision support tools in electronic health record systems that guide prescribers on appropriate drug therapy regimens based on genetic profiles. Additionally, pharmacists can develop institutional guidelines and processes for implementing clinical pharmacogenomics services into various practice settings.
Pharmacists can also develop patient education materials to explain the significance of the tests and serve as expert consultants in a pharmacogenomics service.
Special guest: David Hurley PhD. 
David Hurley grew up in Dunwoody, GA, then earned a BS in Biology and Physics from Guilford College in Greensboro, NC, in 1979. He received his PhD in Molecular and Cellular Biology from Penn State University in 1986. He joined the faculty in Cell and Molecular Biology at Tulane University in New Orleans in 1992. He developed "Cellular Biochemistry" as a senior-level course for premedical students, while maintaining a research focus on the regulation of gene transcription of the Growth Hormone gene in the pituitary. Dr Hurley was an National Science Foundation CAREER program awardee from 1996-2004, and was co-investigator on a National Institutes of Health grant for 17 years. After the devastation of Hurricane Katrina, he joined the Gatton School of Pharmacy at East Tennessee State University as an inaugural faculty member in July, 2007, as Professor and Vice-Chair in the Department of Pharmaceutical Sciences. He has 45 publications, is a member of The Endocrine Society, the Society for Neuroscience, the AACP, and has been a grant reviewer for 6 years with the National Institute for Diabetes, Digestive and Kidney Diseases.
Our host: Becky Winslow, PharmD 
Dr. Becky Winslow is a co-host on PGX for Pharmacists. She’s an accomplished Doctor of Clinical Pharmacy with more than twenty years of clinical pharmacotherapy and pharmacy business operations experience, which includes seven years of direct patient facing care, seven years of pharmacy management experience and six years of experience as a medical science liaison in the pharmacogenomics field. Becky Winslow excels at developing and managing collaborative relationships with healthcare professionals and key opinion leaders to stay abreast of emerging trends and to achieve project goals. Becky Winslow is an articulate communicator with extensive background in gathering and critically analyzing research and data; translating complex content into a level appropriate to the target audience; writing clinical and marketing content; presenting; teaching; and training.
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Clinical Implications & Application of Pharmacogenomics | PGX for Pharmacists

Behnaz Sarrami, MS, PharmD, a PGx for pharmacists podcast, joins Cari Lalande, PharmD where we discuss the clinical value and utility of PGx and how it can be implemented in a clinical setting. 

Pharmacogenomics Rotation of Pharmacy Students | PGx for Pharmacists

Behnaz Sarrami, MS, PharmD, a PGx for pharmacists podcast, Maci Koesterer, PharmD candidate 2021 from St. Louis College of Pharmacy where we discuss her first virtual and unique rotation in PGx and her recommendations to other students.

Thinking Outside the Box | PGx for Pharmacists

Behnaz Sarrami, MS, PharmD, an entrepreneur and a coach in PGx who has started her own consulting business bringing awareness to the clinical value and utility of PGx to providers, pharmacists, and consumers.

Kristine Ashcraft & Becky Winslow, PharmD | PGX For Pharmacists

Kristine Ashcraft, BS, MBA is a molecular biologist by training and is the former CEO and founder of YouScript, recently acquired by Invitae. She has worked in pharmacogenomics since 2000 and was recently named one of the 25 leading voices in precision medicine. Kristine has authored multiple publications on the clinical and economic benefits of pharmacogenomic testing including one lauded as one of the most  influential publications at an American Medical Informatics Association meeting.
Kristine has been interviewed by numerous media outlets including the New York Times, the Wall Street Journal, and NBC Nightly News and has spoken at SXSW, American Society of Human Genetics, and numerous precision medicine conferences. She is committed to catalyzing the adoption of precision medicine.
For all the PGX for Pharmacists episodes, please visit: PGX4RX.com 
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices